Alzheimer’s drug slows mental, functional decline in Eli Lilly trial
By
Alicia Lasek
Jan 12, 2021
Participants who took donanemab for 76 weeks showed 32% slower decline in thinking and daily function compared with those in a placebo group.
Having a good listener in one’s life may help slow cognitive decline: study
By
Alicia Lasek
Aug 18, 2021
Older adults who have regular interactions with active listeners are more likely to have cognitive functioning that contradicts evidence of dementia-related brain changes, a new study finds.
Consuming over-processed foods may hasten cognitive decline: study
By
Alicia Lasek
Dec 09, 2022
High consumption of these foods was linked to a 28% faster rate of global cognitive decline and a 25% faster rate of executive function decline, investigators report.
Amyloid brain plaques not a sure sign of Alzheimer’s, researchers find
By
Alicia Lasek
Jan 12, 2023
A new study challenges the theory that an increase in brain amyloid protein signals Alzheimer’s disease. The findings may be especially relevant to clinicians as amyloid-targeting drugs such as Leqembi...